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Ganglioneuroblastoma is a rare tumor with moderate malignancy, which is composed of mature ganglion cells and seen in
sympathetic ganglia and adrenal medulla. The diagnosis is possible after cytological and immunohistochemical studies following a
needle biopsy or surgical excision. There is no consensus regarding the need for chemo- or radiotherapy after surgery. In this case
report, clinical behavior and diagnosis and treatment of the rare tumor cervical ganglioneuroblastoma were discussed.
1. Introduction
Neuroblastomas are malignant solid tumors. They emerge
from out-of-control, immature cells of the sympathetic
nervous system. Neuroblastomas can emerge in any place
where sympathetic nervous tissues are present.They aremost
commonly seen in suprarenal gland and areas called truncus
sympathicus on neural networks in each side of the spine. In
caseswhere truncus sympathicus is involved, neuroblastomas
can emerge in either side of the spine and in any area
of it [1]. Different levels of microscopic differentiations are
observed in the majority of neuroblastomas. The tumor
may transform into ganglioneuroma on the basis of fibrous
stroma. Various levels of differentiation may be observed
between pure neuroblastoma and pure ganglioneuroma and
these are called ganglioneuroblastoma [1, 2].
In this study, a 5-year-old patient with no complaints
other than neck swelling and a positive pathology of gan-
glioneuroblastoma is presented.
2. Case Report
Five-year-old male patient was admitted to our clinic with
complaint of swelling in the left side of the neck, which was
not accompanied by any pain for four months. He had no
other complaints like loss of weight, fever, night sweating,
respiratory distress, or difficulty swallowing. In the physical
examination, a hard,mobilemass with an approximate size of
2 ∗ 3 cm was detected on the front of musculus sternocleido-
mastoideus in patient’s neck. A neck ultrasonography, which
had been conducted in the external center, had the result of
a lymphadenopathy with the size of 28 ∗ 21mm and with no
fat hilus on musculus sternocleidomastoideus anterior.
Magnetic resonance imaging of the neck showed a prop-
erly limited lesion with 2,8 ∗ 2,3 cm size on the front of
musculus sternocleidomastoideus and internal carotid artery.
The lesion which pushes parotid gland towards the front
was starting from the inferior part of the posterior digastric
muscle and progressing up to the C4 level (Figure 1).
A fine-needle aspiration biopsywas offered but refused by
the family. In his examination 1 month later, the mass in the
neck was found to be approximately 4∗4 cm. Patient’s family
was informed that the mass to be extracted by surgery is deep
under large arteries in the neck, that it may cover nerves
outside the lymph node, and that there are risks of possible
lowering of the left eyelid and in operation of the left vocal
cord. The family gave written consent for the surgery. The
patient underwent the operation with provisional diagnosis
of lymphadenopathy and a tumor of nerve origin.
The properly limited and encapsulated mass on muscu-
lus sternocleidomastoideus, which was pushing the carotid
artery and internal jugular vein into lateral position, was
separated from surrounding tissue by blunt dissection. It was
observed that the mass had nerve continuity in its upper and
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Figure 1: MRI of the head and neck: axial and coronal views of mass. The lesion with 2,8 ∗ 2,3 cm size on the front of musculus
sternocleidomastoideus and internal carotid artery.
lower regions and it was in fact of nerve origin. Nerves in the
upper part were connected by clamping and the nerves which
were severed during blunt dissection were made into another
specimen. The total mass was extracted (Figure 2).
Pathological diagnosis was reported as intermixed type
ganglioneuroblastoma. While there was no calcification on
the encapsulated tumor which was rich in terms of stroma
Schwann cells, it was found that ganglioneuromatosis compo-
nent is over 50%. In addition, differentiation neuroblasts and
immature and dysplastic ganglion cells were observed under
microscopic examination (Figure 3).
Patient had developed ipsilateral Horner syndrome (mio-
sis, ptosis, and anhidrosis) in the postoperative period.
However, no sign of this was found in the 3rd-month con-
trol examination. Tests like abdominal and thorax imaging,
complete blood count, bone marrow aspiration test, 24-hour
urinary VMA, and N-myc protooncogene protein scan were
conducted. No pathological findings were observed. After the
I-131Metaiodobenzylguanidine (I-131MIBG) scan in the 6th-
month control examination, an involvement was observed in
the right cervical region, the opposite area of the operated
region, and patient was directed to adjuvant chemotherapy.
No evidence of any recurrence was found in the 12th-month
control examination.
3. Discussion
Cervical masses are common pathologies in the pediatric
population. While most of them are benign such as inflam-
matory or congenital ones, over 10% of biopsies extracted
from suspicious masses are being reported as malign [2].
Ganglioneuroblastomas represent a histological subgroup of
rare neuroblastic tumors with moderate malignancy poten-
tial, which originate fromneural crest progenitor cells of sym-
pathetic nerve cells. They are very difficult to diagnose using
only physical examination and imaging methods. Gener-
ally, final diagnosis is possible after cytological and immuno-
histochemical studies following a surgical excision.
Neuroblastic tumors are divided into four types in Inter-
national Neuroblastoma Pathology Classification: neurob-
lastoma, intermixed ganglioneuroblastoma, modular gan-
glioneuroblastoma, and ganglioneuroma [3]. The type our
case study reports, intermixed ganglioneuroblastoma, was
reported in several studies in the literature. While in those
publications this type of mass was reported to cause respi-
ratory distress and difficulties in swallowing, our case study
reported none of these symptoms.
The International Neuroblastoma Risk Group (INRG)
classification system was developed to establish a consensus
approach for pretreatment risk stratification. The Interna-
tional Neuroblastoma Staging System (INSS) is a postsur-
gical staging system. In the INRG classification system, a
combination of clinical, pathologic, and genetic markers is
used to predict whether the tumor will grow and how it
will respond to treatment. These markers are used to define
risk. Using the following factors, neuroblastoma is classified
into 1 of 4 categories: very low-risk, low-risk, intermediate-
risk, or high-risk. INRG includes the following: the stage of
the disease according to the INRG Staging System, age at
the time of diagnosis, histologic category, such as maturing
ganglioneuroma versus ganglioneuroblastoma, intermixed
versus ganglioneuroblastoma, or nodular versus neuroblas-
toma, grade or how cells of the tumor are differentiated,
MYCN gene status, chromosome 11q status, and tumor cell
ploidy, which is the DNA content of tumor cells.
The INRGStaging System (INRGSS)was designed specif-
ically for the INRG pretreatment classification system. It does
not include surgical results or spread to lymph nodes to
determine the stage. Knowledge regarding the presence or
absence of image defined risk factors (IDRFs) is required for
this staging system. Stage L1: the tumor is located only in the
area where it started; no IDRFs are found on imaging scans,
such asCTorMRI. Stage L2: the tumor has not spread beyond
the area where it started and the nearby tissue; IDRFs are
found on imaging scans, such as CT or MRI. Stage M: the
tumor has spread to other parts of the body. Stage MS: the
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Figure 2: (a) Intraoperative view of the neurogenic mass. (b) The lesion with 4 cm size after the total excision. (c) Upper part of the nerve
was held by the clamp.
(a) (b)
Figure 3: Photomicrographs showing more than 50% of tumor tissue in this case composed of Schwannian stroma and neuropil-like islands,
differentiating neuroblasts, and immature and dysplastic ganglion cells. H&E (a and b), original magnification (a) 10x and (b) 40x.
tumor has spread to only the skin, liver, and/or bone marrow
(less than 10%bonemarrow involvement) in patients younger
than 18 months [4].
Al-Jassim had stated that in his case study of 2-year-
old patient with ganglioneuroblastoma the patient had devel-
oped postoperative Horner syndrome, but this had been
resolved spontaneously over time [5]. Moukheiber et al. had
reported in their study that 3 patients had primary cervical
ganglioneuroblastoma and developed nerve paresis in the
postoperative period [6]. Due to the risk of postoperative
nerve palsy being high, parents and children should be
informed in detail before the operation. As it happened in
our case study, if the mass was found to be of nerve origin,
the parents should absolutely be informed about possible
complications (Horner syndrome due to sympathetic nerve
chain incision, respiratory and nutrition problems due to
vagal nerve incision, etc.) and their consent should be taken.
There is no doubt that imaging techniques are not enough
for a definitive diagnosis. Magnetic resonance imaging is rec-
ommended. Ganglioneuroblastoma is typically heterogenous
in imaging. Generally it shows high signal intensity in T1
images and low signal intensity in T2 images [5, 6]. However,
as it happened in our case, it may show hypointense charac-
teristics in T1 and hyperintense characteristics in T2, which
may lead to misdiagnosis. First, a fine-needle biopsy should
be offered for diagnosis. Following that, a staged treatment
planmay be tailored according to histopathological diagnosis
and body scan results [6, 7]. In our case, our patient’s parents
initially refused our suggestion of fine-needle aspiration and
stated that they want to continue monitoring the situation.
However, after the mass was found to have grown in size
during control examination, patient was offered excisional
biopsywith a prediagnosis of lymphadenopathy. After finding
that themass is of nerve origin, it was totally extracted and the
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examination of metastasis or primary tumor was conducted
in postoperative period.
It is known that most neurogenic tumors secrete cate-
cholamine.High levels of catecholaminemay be an indication
of recurrence or the presence of primary tumor. Genetic
characteristics are also associated with tumor behavior. N-
myc is a protooncogen, where its chromosome arm resides in
far end of 2p. Detection of multiple N-myc copies indicates
a fast tumor growth and negative prognosis in patients who
show these histological characteristics and are over 1 year
of age. Also a scintigraphic scan with MIBG should be
conducted and invasion should be determined. In our patient,
vanilmandelic acid (VMA) and N-myc protooncogene
were found to be negative during the postoperative period
[6–8].
The need for chemotherapy in postoperative period can
be decided after a systematic scan was conducted. In one
literature study, a myelogram of a patient, who was under
1 year of age, had showed metastatic cells and the patient
had underwent postoperative chemotherapy. Some authors
advocate giving chemotherapy even when there is no metas-
tasis, due to ganglioneuroblastoma being a malignant tumor
in nature [6–8]. In our patient, while there was no evidence
of recurrence until the 6th month after the operation, PET-
BT scan at the 6th month showed an involvement in the right
side of the neck, and patient was given chemotherapy. After
2 sessions of chemotherapy, no recurrence was found in the
12th-month control examination of the patient.
4. Conclusion
In this case study, our aimwas to discuss clinical behavior and
diagnosis and treatment of primary cervical ganglioneurob-
lastoma together with the literature review. Ganglioneurob-
lastomas in cervical ganglions are rather rare tumors.They are
usually asymptomatic, thus making preoperative diagnosis
difficult. Clinicians should bear this in mind as this is found
in the differential diagnosis of masses in parapharyngeal
space.
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